The Epidemiological and Economic Impact of a Cell-Based Quadrivalent Influenza Vaccine in Adults in the US: A Dynamic Modeling Approach
Open Access
Abstract
Mutations of the H3N2 vaccine strain during the egg-based vaccine manufacturing process partly explain the suboptimal effectiveness of traditional seasonal influenza vaccines. Cell-based influenza vaccines improve antigenic match and vaccine effectiveness by avoiding such egg-adaptation. This study evaluated the public health and economic impact of a cell-based quadrivalent influenza vaccine (QIVc) in adults (18–64 years) compared to the standard egg-based quadrivalent influenza vaccine (QIVe) in the US. The impact of QIVc over QIVe in public health and cost outcomes was estimated using a dynamic age-structured SEIR transmission model, which accounted for four circulating influenza strains [A/H1N1pdm9, A/H3N2, B(Victoria), and B(Yamagata)] and was calibrated on the 2013–2018 influenza seasons. The robustness of the results was assessed in univariate and probabilistic sensitivity analyses. Switching from QIVe to QIVc in 18- to 64-year-olds may prevent 5.7 million symptomatic cases, 1.8 million outpatient visits, 50,000 hospitalizations, and 5453 deaths annually. The switch could save 128,000 Quality-Adjusted Life Years (QALYs) and US $ 845 M in direct costs, resulting in cost-savings in a three-year time horizon analysis. Probabilistic sensitivity analyses confirmed the robustness of the cost-saving result. The analysis shows that QIVc is expected to prevent hospitalizations and deaths, and result in substantial savings in healthcare costs.Keywords
All Related Versions
Funding Information
- Seqirus USA Inc. (n/a)
This publication has 32 references indexed in Scilit:
- Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling StudyPLOS Medicine, 2013
- Indirect, out-of-pocket and medical costs from influenza-related illness in young childrenVaccine, 2012
- Viral shedding in children infected by pandemic A/H1N1/2009 influenza virusVirology Journal, 2011
- Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination in ChildrenThe Pediatric Infectious Disease Journal, 2008
- Using Time-Use Data to Parameterize Models for the Spread of Close-Contact Infectious DiseasesAmerican Journal of Epidemiology, 2008
- Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY thresholdExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious DiseasesPLOS Medicine, 2008
- Time Lines of Infection and Disease in Human Influenza: A Review of Volunteer Challenge StudiesAmerican Journal of Epidemiology, 2008
- Strategies for containing an emerging influenza pandemic in Southeast AsiaNature, 2005
- A Simplex Method for Function MinimizationThe Computer Journal, 1965